The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Fc receptors in antibody‐dependent enhancement of viral infections
Open accessAbstract
Summary: Sensitization of the humoral immune response to invading viruses and production of antiviral antibodies forms part of the host antiviral repertoire. Paradoxically, for a number of viral pathogens, under certain conditions, antibodies provide an attractive means of enhanced virus entry and replication in a number of cell types. Known as antibody‐dependent enhancement (ADE) of infection, the phenomenon occurs when virus‐antibody immunocomplexes interact with cells bearing complement or Fc receptors, promoting internalization of the virus and increasing infection. Frequently associated with exacerbation of viral disease, ADE of infection presents a major obstacle to the prevention of viral disease by vaccination and is thought to be partly responsible for the adverse effects of novel antiviral therapeutics such as intravenous immunoglobulins. There is a growing body of work examining the intracellular signaling pathways and epitopes responsible for mediating ADE, with a view to aiding rational design of antiviral strategies. With in vitro studies also confirming ADE as a feature of infection for a growing number of viruses, challenges remain in understanding the multilayered molecular mechanisms of ADE and its effect on viral pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–216 of 216
Medin, C. L., & Rothman, A. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/502630 · Cited by 34
de Souza, K. P. R., Silva, E. G., Rocha, E. S. D. O., Figueiredo, L. B., Almeida‐Leite, C. M., Arantes, R. M. E., Gomes, J. D. A. S., Ferreira, G. P., de Oliveira, J. G., Kroon, E. G., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-267 · Cited by 33
Chang, S., Wang, J., Huang, L., Chen, Y., Fang, C., Sheng, W., Wang, J., Yu, C., & Yang, P. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.12.1455-1457.2005 · Cited by 32
Costa, V. V., Fagundes, C. T., Valadão, D. F., Ávila, T. V., Cisalpino, D., Rocha, R. D. P. F., Ribeiro, L. S., Ascenção, F. R., Kangussu, L. M., Celso, M. Q., et al. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0334-5 · Cited by 31
Ochiai, H., Kurokawa, M., Kuroki, Y., & Niwayama, S. (1990) · Journal of Medical Virology · doi:10.1002/jmv.1890300406 · Cited by 27
Carvalho, D. M., Garcia, F. G., Terra, A. P. S., Tosta, A. C. L., Teixeira, L. D. A. S., Castellano, L. R. C., & Teixeira, D. N. S. (2014) · Journal of Tropical Medicine · doi:10.1155/2014/901276 · Cited by 27
Pilsbury, L. E., Allen, R. L., & Vordermeier, M. H. (2010) · Mediators of Inflammation · doi:10.1155/2010/536478 · Cited by 27
The Clinical Response of West Nile Virus Neuroinvasive Disease to Intravenous Immunoglobulin Therapy
Shimoni, Z., Bin, H., Bulvik, S., Niven, M. J., Hazzan, R., Mendelson, E., & Froom, P. (2012) · Clinics and Practice · doi:10.4081/cp.2012.e18 · Cited by 25
Skowronski, D. M., Hamelin, M., Serres, G. D., Janjua, N. Z., Li, G., Sabaiduc, S., Bouhy, X., Couture, C., Leung, A., Kobasa, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086555 · Cited by 24
Chen, R., Wang, L., Cheng, J., & Yang, K. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-340 · Cited by 23
Strengthening Observational Evidence for Antiviral Effectiveness in Influenza A (H5N1)
Adisasmito, W. B. B., Chan, P. K. S., Lee, N. L. S., Öner, A. F., Gasimov, V., Zaman, M., Bamgboye, E. L., Doğan, N., Starzyk, K. A., Dreyer, N. A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir398 · Cited by 20
Matsuura, C., Moraes, T. L., Barbosa, J. B., Moss, M. B., Siqueira, M. A. S., Mann, G. E., Neto, M. L., Brunini, T. M. C., & Mendes‐Ribeiro, A. C. (2012) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2011.10.009 · Cited by 18
Ju, H., & Brasier, A. R. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-365 · Cited by 18
Dutry, I., Yen, H., Lee, H. H. Y., Peiris, M. J. S., & Jaume, M. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s1-p62 · Cited by 13
Toll-Like Receptor 4 Polymorphisms in Dengue Virus–Infected Children
Djamiatun, K., Ferwerda, B., Netea, M. G., van der Ven, A. J. A. M., Dolmans, W. M. V., & Faradz, S. M. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0728 · Cited by 12
Is There Still Hope After Prions Have Spread Within the Brain?
Carnaud, C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir487 · Cited by 2
Cited by
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., Chen, R. E., Carter, L., Walls, A. C., Park, Y.-J., et al. (2020) · Science · doi:10.1126/science.abd9909 · Cited by 742
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 572
Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., Zost, S. J., Jang, H., Huang, Y., Allen, J. D., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.026 · Cited by 366
Muralidar, S., Ambi, S. V., Sekaran, S., & Krishnan, U. M. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.018 · Cited by 346
Metadata
- Authors
- Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-10-26
- Volume
- 268
- Issue
- 1
- Pages
- 340-364
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2102144534
- Cited by
- 255
- References
- 216
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.